The vast majority of colon cancers do start as polyps. More than 95% of colorectal cancers arise from adenomatous polyps, which are small, initially benign growths on the inner lining of the colon. These polyps accumulate genetic damage over time, and a small percentage of them eventually become cancerous. The typical timeline from polyp to cancer is a decade or more, which is exactly why screening colonoscopies are so effective: they catch and remove polyps long before they ever get the chance to turn malignant.
How a Normal Cell Becomes a Polyp, Then Cancer
Colon cancer follows a well-established progression. It starts when the genes controlling cell growth and DNA repair in the colon lining pick up mutations. The earliest and most common trigger is a mutation in a tumor-suppressing gene called APC, which normally keeps cell growth in check. Once that gene stops working, cells begin multiplying when they shouldn’t, forming a small clump of tissue that bulges out from the colon wall. That’s a polyp.
A polyp doesn’t become dangerous overnight. Over years, additional mutations stack up. Genes that promote growth get switched on, while genes that suppress tumors or trigger damaged cells to self-destruct get switched off. As these changes accumulate, the polyp grows larger and its cells become increasingly abnormal. Late-stage mutations, particularly in the TP53 gene (a critical tumor suppressor), are what finally push a polyp from precancerous to invasive cancer. This entire sequence, from first mutation to invasive disease, typically takes 10 years or longer.
Not All Polyps Are Precancerous
Finding a polyp on a colonoscopy doesn’t automatically mean you’re on a path to cancer. Polyps fall into two broad categories: neoplastic (capable of becoming cancer) and non-neoplastic (not capable).
Neoplastic polyps, the ones that matter, include:
- Adenomatous polyps (adenomas). These account for about 80% of all colon polyps and are the source of roughly 75% of colorectal cancers. They come in subtypes: tubular adenomas carry the lowest risk, villous adenomas carry the highest, and tubulovillous adenomas fall in between.
- Sessile serrated lesions and traditional serrated adenomas. These have a distinctive saw-tooth shape under the microscope and were long considered harmless. They’re now recognized as a significant source of cancers that appear between scheduled screenings, partly because they’re flat and harder to spot during a colonoscopy.
Non-neoplastic polyps, which don’t turn cancerous on their own, include hyperplastic polyps (very common, especially in the lower colon, and almost always harmless), inflammatory pseudopolyps (scar-like bumps from healed ulcers, often seen in people with inflammatory bowel disease), and hamartomatous polyps (usually benign in isolation, though rare genetic syndromes involving many of them can raise cancer risk).
Only a Small Fraction of Polyps Turn Malignant
Here’s the reassuring part: even among adenomas, the ones with real cancer potential, only about 5% actually become malignant. The risk of any average-size colon polyp progressing to cancer is estimated at 8% over 10 years and 24% over 20 years. Size is the single biggest predictor. The larger a precancerous polyp grows, the greater the chance it harbors dangerous mutations. This is why removing polyps when they’re small is so effective at preventing cancer altogether.
The Serrated Pathway: A Less Obvious Route
The classic adenoma-to-cancer progression accounts for most colon cancers, but it’s not the only one. A second route, called the serrated pathway, begins with a different initiating mutation (in the BRAF gene rather than APC) and produces flat, serrated polyps instead of the typical raised adenomas. These lesions look different, behave differently, and are a leading cause of “interval” cancers, meaning cancers that show up between routine screenings. Because serrated lesions are flat and pale, they blend in with the surrounding colon lining and can be missed even by experienced doctors. Despite following a different molecular path, the timeline from serrated polyp to cancer is still generally a decade or more.
Genetic Conditions That Change the Rules
For most people, the polyp-to-cancer timeline is slow and predictable. Certain inherited conditions speed things up dramatically.
Lynch syndrome (also called hereditary non-polyposis colorectal cancer) is the most common cause of hereditary colon cancer. People with Lynch syndrome carry mutations in genes responsible for fixing DNA copying errors. They may develop relatively few polyps, but the ones they do develop can become cancerous much more quickly than usual, often before age 50.
Familial adenomatous polyposis (FAP) sits at the other extreme. This rare condition causes hundreds or even thousands of polyps to carpet the colon, typically starting in the teenage years. Without treatment, the sheer number of polyps makes cancer virtually inevitable, usually before age 40. The risk approaches 100%.
Why Polyps Rarely Cause Symptoms
Most colon polyps produce no symptoms at all. They’re too small to cause pain, bleeding, or changes in bowel habits. This is precisely what makes them dangerous: by the time a polyp grows large enough to cause noticeable rectal bleeding, a change in stool color, or a shift in bowel patterns, it may already be quite advanced. Colon cancer that has grown beyond the polyp stage is far more likely to produce symptoms, but waiting for symptoms means missing the window when the disease is easiest to prevent.
How Screening Breaks the Chain
The slow pace of the polyp-to-cancer sequence is what makes colon cancer one of the most preventable cancers. The U.S. Preventive Services Task Force recommends screening starting at age 45 for all adults, with the strongest recommendation (Grade A) for adults 50 to 75.
Colonoscopy every 10 years is the most thorough option because it allows doctors to both find and remove polyps in the same procedure. If a colonoscopy isn’t feasible, stool-based tests (done yearly or every one to three years depending on the type), flexible sigmoidoscopy every five years, or CT colonography every five years are alternatives. Any abnormal result from these less invasive tests requires a follow-up colonoscopy. These screening intervals apply to people with negative findings. If polyps are found and removed, your doctor will recommend a shorter follow-up schedule based on the number, size, and type of polyps.
Removing a precancerous polyp during a colonoscopy eliminates its ability to ever become cancer. That 10-plus-year window between polyp formation and malignancy means that for most people, regular screening can catch the problem long before it becomes life-threatening.